In keeping with experimental data suggesting its role as a tumor suppressor [7,12,13], RNASET2 expression has been so far associated to less aggressive phenotypes in several cancer models, including ovarian cancer [7,8,9,13,14]. This evidence concerns the gene RNASET2 and ovarian carcinoma.